Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
about
Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy.Primary IgA nephropathy: current challenges and future prospects.Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway.
P2860
Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Targeting C3a/C5a receptors in ...... lobulin A nephropathy in mice.
@en
type
label
Targeting C3a/C5a receptors in ...... lobulin A nephropathy in mice.
@en
prefLabel
Targeting C3a/C5a receptors in ...... lobulin A nephropathy in mice.
@en
P2093
P2860
P356
P1476
Targeting C3a/C5a receptors in ...... lobulin A nephropathy in mice.
@en
P2093
P2860
P356
10.1111/CEI.12961
P50
P577
2017-03-15T00:00:00Z